Atossa Therapeutics Ownership | Who Owns Atossa Therapeutics?


OverviewForecastFinancialsChartTranscripts

Atossa Therapeutics Ownership Summary


Atossa Therapeutics is owned by 21.95% institutional investors, 0.07% insiders, and 77.97% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 7.76% of ATOS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.05% of its assets in Atossa Therapeutics shares.

ATOS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAtossa Therapeutics21.95%0.07%77.97%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de9.76M7.76%$9.21M
Blackrock9.20M7.34%$10.94M
Vanguard group6.62M5.26%$6.25M
Geode capital management2.81M2.24%$2.66M
State street1.76M1.40%$1.66M
Renaissance1.56M1.24%$1.47M
Ubs group1.12M0.89%$1.06M
Morgan stanley456.15K0.36%$542.82K
Jpmorgan chase361.30K0.29%$341.10K
Goldman sachs group344.86K0.27%$325.58K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Lvm capital management ltd/mi21.00K0.00%$20.00K
Renaissance1.56M0.00%$1.47M
J. l. bainbridge11.12K0.00%$10.50K
Pfg investments14.90K0.00%$14.07K
Connor, clark & lunn investment management189.32K0.00%$178.74K
Planning capital management1.00K0.00%$1.19K
Intech investment management62.84K0.00%$59.33K
Evanson asset management10.00K0.00%$9.44K
Northrock partners16.75K0.00%$15.81K
Ameritas investment partners12.39K0.00%$11.70K

Top Buyers

HolderShares% AssetsChange
Blackrock9.20M0.00%6.45M
Ubs group1.12M0.00%1.05M
Renaissance1.56M0.00%247.56K
Jpmorgan chase361.30K-211.65K
Susquehanna group, llp226.18K-154.40K

Top Sellers

HolderShares% AssetsChange
Laurion capital management lp---2.23M
Morgan stanley456.15K--309.26K
Virtu financial---208.20K
Point72 asia (singapore) pte.---140.86K
Jane street group---126.70K

New Positions

HolderShares% AssetsChangeValue
Raymond james financial18.82K-18.82K$17.76K
Cibc world markets11.84K0.00%11.84K$11.18K
Sg americas securities11.81K0.00%11.81K$14.00K
Janney montgomery scott11.50K-11.50K$14.00K
Planning capital management1.00K0.00%1.00K$1.19K

Sold Out

HolderChange
Capital performance advisors llp-25.00
Delos wealth advisors-100.00
Nbc securities-150.00
Old point trust & financial services n a-250.00
Cwm-394.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202586-1.15%28,358,791-5.26%213.88%27-32.50%3147.62%
Dec 31, 202487-4.40%29,932,7169.47%235.04%4011.11%21-19.23%
Sep 30, 20249112.35%27,343,7514.42%214.98%37-22.92%2578.57%
Jun 30, 20248114.08%26,186,18535.76%208.82%4829.73%1344.44%
Mar 31, 20247142.00%19,288,84520.98%159.58%37236.36%9-43.75%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv3.94M3.05%-
Vanguard US Total Market Shares ETF3.94M3.05%-
iShares Russell 2000 ETF3.21M2.49%1.57K
Vanguard Institutional Extnd Mkt Idx Tr1.67M1.29%-
Fidelity Small Cap Index1.28M0.99%-
iShares Russell 2000 Value ETF1.01M0.78%-
Fidelity Extended Market Index648.46K0.50%-4.04K
Vanguard Russell 2000 ETF626.36K0.48%35.00K
State St Russell Sm Cap® Indx SL Cl I549.72K0.43%-
Schwab Small Cap Index342.58K0.27%-

Recent Insider Transactions


DateNameRoleActivityValue
May 21, 2025QUAY STEVEN C President & CEOBuy$9.89K
Mar 26, 2025Remmel H. Lawrence-Buy$7.00K
Apr 10, 2024Finn Jonathan-Buy$44.25K
Nov 15, 2023WEAVER GREGORY L Former EVP, CFO, & DirectorSell$32.50K
Jun 20, 2023WEAVER GREGORY L EVP & CFOBuy$48.50K

Insider Transactions Trends


DateBuySell
2025 Q21-
2025 Q11-
2024 Q21-
2024 Q1--
2023 Q4-1

ATOS Ownership FAQ


Who Owns Atossa Therapeutics?

Atossa Therapeutics shareholders are primarily institutional investors at 21.95%, followed by 0.07% insiders and 77.98% retail investors. The average institutional ownership in Atossa Therapeutics's industry, Biotech Stocks , is 63.96%, which Atossa Therapeutics falls below.

Who owns the most shares of Atossa Therapeutics?

Atossa Therapeutics’s largest shareholders are Blackrock funding, inc. /de (9.76M shares, 7.76%), Blackrock (9.2M shares, 7.34%), and Vanguard group (6.62M shares, 5.26%). Together, they hold 20.36% of Atossa Therapeutics’s total shares outstanding.

Does Blackrock own Atossa Therapeutics?

Yes, BlackRock owns 7.34% of Atossa Therapeutics, totaling 9.2M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 10.94M$. In the last quarter, BlackRock increased its holdings by 6.45M shares, a 234.28% change.

Who is Atossa Therapeutics’s biggest shareholder by percentage of total assets invested?

Lvm capital management ltd/mi is Atossa Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 21K Atossa Therapeutics shares, valued at 20K$.

Who is the top mutual fund holder of Atossa Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Atossa Therapeutics shares, with 3.05% of its total shares outstanding invested in 3.94M Atossa Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools